CMV immune evasion and manipulation of the immune system with aging

GeroScience

Volumn 39, Issue 3, 2017, Pages 273-291

  Jackson, Sarah E ^a   Redeker, Anke ^b   Arens, Ramon ^b   van Baarle, Debbie ^c,d   van den Berg, Sara P H ^c,d   Benedict, Chris A ^e   Čičin Šain, Luka ^f,g   Hill, Ann B ^h   Wills, Mark R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^f HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aging; Cytomegalovirus; Immune evasion; Immune manipulation

Indexed keywords

CYTOMEGALOVIRUS VACCINE;

AGE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FIBROBLAST; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSENESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS DOSE; INFLUENZA VIRUS; INOCULATION; LATENT PERIOD; MORBIDITY; NONHUMAN; REVIEW; T LYMPHOCYTE; VACCINATION; VIRUS CARRIER; VIRUS MUTANT; AGED; AGING; ANIMAL; CYTOMEGALOVIRUS; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MOUSE; ORGANIZATION; VIRUS LATENCY; VIRUS REPLICATION;

AGED; AGING; ANIMALS; CONGRESSES AS TOPIC; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNE EVASION; IMMUNOLOGIC MEMORY; MICE; VIRUS LATENCY; VIRUS REPLICATION;

EID: 85021220410     PISSN: 25092715     EISSN: 25092723     Source Type: Journal    
DOI: 10.1007/s11357-017-9986-6     Document Type: Review

References (147)

1. Adler SP et al (2016) A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimera vaccines in cytomegalovirus-seronegative men. J Infect Dis 214:1341–1348. doi:10.1093/infdis/jiw365
2. Akbar AN, Soares MVD, Plunkett FJ, Salmon M (2001) Differential regulation of CD8+ T cell senescence in mice and men. Mech Ageing Dev 121:69–76. doi:10.1016/s0047-6374(00)00198-6
3. Alonso Arias R, Moro-Garcia MA, Echeverria A, Solano-Jaurrieta JJ, Suarez-Garcia FM, Lopez-Larrea C (2013) Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J Virol 87:4486–4495. doi:10.1128/JVI.02425-12
4. Amsler L, Verweij MC, DeFilippis VR (2013) The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. J Mol Biol 425:4857–4871. doi:10.1016/j.jmb.2013.08.023
5. Appay V, Sauce D (2014) Naive T cells: the crux of cellular immune aging? Exp Gerontol 54:90–93. doi:10.1016/j.exger.2014.01.003
6. Arens R et al (2008) Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J Immunol 180:6472–6476
7. Benedict CA et al (1999) Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162:6967–6970
8. Blum KS, Pabst R (2007) Lymphocyte numbers and subsets in the human blood: do they mirror the situation in all organs? Immunol Lett 108:45–51
9. Bodaghi B et al (1998) Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188:855–866
10. Bohm V et al (2008) The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation. J Virol 82:11637–11650. doi:10.1128/JVI.01510-08
11. Broadley I, Pera A, Morrow G, Davies KA, Kern F (2017) Expansions of cytotoxic CD4+CD28- T cells drive excess cardiovascular mortality in rheumatoid arthritis and other chronic inflammatory conditions and are triggered by CMV infection. Front Immunol 8:195. doi:10.3389/fimmu.2017.00195
12. Carbone J (2016) The immunology of posttransplant CMV infection: potential effect of CMV immunoglobulins on distinct components of the immune response to CMV. Transplantation 100(Suppl 3):S11–S18. doi:10.1097/TP.0000000000001095
13. Chan ST, Logan AC (2017) The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: why the quest for meaningful prophylaxis still matters. Blood Rev. doi:10.1016/j.blre.2017.01.002
14. Chang WL, Barry PA (2010) Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity. Proc Natl Acad Sci U S A 107:22647–22652. doi:10.1073/pnas.1013794108
15. Cheung TC et al (2005) Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci U S A 102:13218–13223. doi:10.1073/pnas.0506172102
16. Cheung AK et al (2009) The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency. Blood 114:4128–4137. doi:10.1182/blood-2008-12-197111
17. Christiaansen A, Varga SM, Spencer JV (2015) Viral manipulation of the host immune response. Curr Opin Immunol 36:54–60. doi:10.1016/j.coi.2015.06.012
18. Cicin-Sain L, Bubic I, Schnee M, Ruzsics Z, Mohr C, Jonjic S, Koszinowski UH (2007) Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. J Virol 81:13825–13834. doi:10.1128/JVI.01911-07
19. Cicin-Sain L et al (2011) Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques. J Immunol 187:1722–1732. doi:10.4049/jimmunol.1100560
20. Cicin-Sain L, Brien JD, Uhrlaub JL, Drabig A, Marandu TF, Nikolich-Zugich J (2012) Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging. PLoS Pathog 8:e1002849. doi:10.1371/journal.ppat.1002849
21. Clement M et al (2016) Cytomegalovirus-specific IL-10-producing CD4+ T cells are governed by type-I IFN-induced IL-27 and promote virus persistence. PLoS Pathog 12:e1006050. doi:10.1371/journal.ppat.1006050
22. Cope AV, Sweny P, Sabin C, Rees L, Griffiths PD, Emery VC (1997) Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol 52:200–205
23. Crough T, Khanna R (2009) Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 22:76–98, Table of Contents. doi:10.1128/CMR.00034-08
24. de Groot NG, Blokhuis JH, Otting N, Doxiadis GG, Bontrop RE (2015) Co-evolution of the MHC class I and KIR gene families in rhesus macaques: ancestry and plasticity. Immunol Rev 267:228–245. doi:10.1111/imr.12313
25. Dekhtiarenko I, Jarvis MA, Ruzsics Z, Cicin-Sain L (2013) The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigens. J Immunol 190:3399–3409. doi:10.4049/jimmunol.1203173
26. Dekhtiarenko I et al (2016) Peptide processing is critical for T-cell memory inflation and may be optimized to improve immune protection by CMV-based vaccine vectors. PLoS Pathog 12:e1006072. doi:10.1371/journal.ppat.1006072
27. den Elzen WP, Vossen AC, Cools HJ, Westendorp RG, Kroes AC, Gussekloo J (2011) Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine 29:4869–4874. doi:10.1016/j.vaccine.2011.03.086
28. Denkinger MD, Leins H, Schirmbeck R, Florian MC, Geiger H (2015) HSC aging and senescent immune remodeling. Trends Immunol 36:815–824. doi:10.1016/j.it.2015.10.008
29. Derhovanessian E, Theeten H, Hahnel K, Van Damme P, Cools N, Pawelec G (2013) Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 31:685–690. doi:10.1016/j.vaccine.2012.11.041
30. Derhovanessian E, Maier AB, Hahnel K, McElhaney JE, Slagboom EP, Pawelec G (2014) Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol 193:3624–3631. doi:10.4049/jimmunol.1303361
31. Derhovanessian E et al (2015) CCR4+ regulatory T cells accumulate in the very elderly and correlate with superior 8-year survival. J Gerontol A Biol Sci Med Sci 70:917–923. doi:10.1093/gerona/glu128
32. Doring M et al (2014) M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells. J Virol 88:13638–13650. doi:10.1128/JVI.00216-14
33. Fleck M, Kern ER, Zhou T, Podlech J, Wintersberger W, Edwards CK 3rd, Mountz JD (1998) Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus. J Clin Invest 102:1431–1443. doi:10.1172/JCI3248
34. Fliss PM, Brune W (2012) Prevention of cellular suicide by cytomegaloviruses. Viruses 4:1928–1949. doi:10.3390/v4101928
35. Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB (2015) Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine 33:1433–1439. doi:10.1016/j.vaccine.2015.01.071
36. Furman D et al (2015) Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med 7:281ra243. doi:10.1126/scitranslmed.aaa2293
37. Furui Y, Satake M, Hoshi Y, Uchida S, Suzuki K, Tadokoro K (2013) Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors. Transfusion 53:2190–2197. doi:10.1111/trf.12390
38. Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ (2012) Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. J Infect Dis 206:1897–1903. doi:10.1093/infdis/jis620
39. Goodrum F (2016) Human cytomegalovirus latency: approaching the Gordian knot. Annu Rev Virol 3:333–357. doi:10.1146/annurev-virology-110615-042422
40. Gordon CL et al (2017) Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection. J Exp Med 214:651–667. doi:10.1084/jem.20160758
41. Hadrup SR et al (2006) Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 176:2645–2653
42. Hansen SG et al (2009) Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15:293–299. doi:10.1038/nm.1935
43. Hansen SG et al (2013a) Immune clearance of highly pathogenic SIV infection. Nature 502:100–104. doi:10.1038/nature12519
44. Hansen SG et al (2013b) Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 340:1237874. doi:10.1126/science.1237874
45. Haq K et al (2016) Cytomegalovirus seropositivity predicts a decline in the T cell but not the antibody response to influenza in vaccinated older adults independent of type 2 diabetes status. J Gerontol A Biol Sci Med Sci. doi:10.1093/gerona/glw216
46. Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ (2000) Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 74:11495–11503
47. Humphreys IR, de Trez C, Kinkade A, Benedict CA, Croft M, Ware CF (2007) Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J Exp Med 204:1217–1225. doi:10.1084/jem.20062424
48. Hutchinson S, Sims S, O'Hara G, Silk J, Gileadi U, Cerundolo V, Klenerman P (2011) A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS One 6:e14646. doi:10.1371/journal.pone.0014646
49. Jackson SE, Mason GM, Wills MR (2011) Human cytomegalovirus immunity and immune evasion. Virus Res 157:151–160. doi:10.1016/j.virusres.2010.10.031
50. Jackson SE, Mason GM, Okecha G, Sissons JG, Wills MR (2014) Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells. J Virol 88:10894–10908. doi:10.1128/JVI.01477-14
51. Jackson SE, Sedikides GX, Mason GM, Okecha G, Wills MR (2017a) Human cytomegalovirus (HCMV)-specific CD4+ T cells are polyfunctional and can respond to HCMV-infected dendritic cells. In Vitro J Virol 91:16. doi:10.1128/JVI.02128-16
52. Jackson SE, Sedikides GX, Okecha G, Poole EL, Sinclair JH, Wills MR (2017b) Latent cytomegalovirus (CMV) infection does not detrimentally alter T cell responses in the healthy old; but increased latent CMV carriage is related to expanded CMV specific T cells. Front Immunol doi:10.3389/fimmu.2017.00733
53. Jenkins C, Abendroth A, Slobedman B (2004) A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 78:1440–1447
54. Jenkins C, Garcia W, Godwin MJ, Spencer JV, Stern JL, Abendroth A, Slobedman B (2008) Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. J Virol 82:3736–3750. doi:10.1128/JVI.02173-07
55. Jones M et al (2010) IL-10 restricts memory T cell inflation during cytomegalovirus infection. J Immunol 185:3583–3592. doi:10.4049/jimmunol.1001535
56. Jost NH et al (2014) Regulatory T cells and T-cell-derived IL-10 interfere with effective anti-cytomegalovirus immune response. Immunol Cell Biol 92:860–871. doi:10.1038/icb.2014.62
57. Kagan KO, Hamprecht K (2017) Cytomegalovirus infection in pregnancy. Arch Gynecol Obstet. doi:10.1007/s00404-017-4380-2
58. Karrer U et al. (2003) Memory inflation: continuous accumulation of antiviral CD8(+) T cells over time. (vol 170, pg 2022, 2003). J Immunol 171:3895–3895 doi:10.4049/jimmunol.171.7.3895-b
59. Kim S et al (2011) Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 12:984–991. doi:10.1038/ni.2097
60. Kim Y, Lee S, Kim S, Kim D, Ahn JH, Ahn K (2012) Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection. PLoS Pathog 8:e1002577. doi:10.1371/journal.ppat.1002577
61. Kline KA, Bowdish DM (2016) Infection in an aging population. Curr Opin Microbiol 29:63–67. doi:10.1016/j.mib.2015.11.003
62. Komatsu H, Sierro S, Cuero AV, Klenerman P (2003) Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin Exp Immunol 134:9–12
63. Kouri V et al (2010) Diagnosis and screening for cytomegalovirus infection in pregnant women in Cuba as prognostic markers of congenital infection in newborns: 2007-2008. Pediatr Infect Dis J 29:1105–1110. doi:10.1097/INF.0b013e3181eb7388
64. Kurz SK, Rapp M, Steffens HP, Grzimek NK, Schmalz S, Reddehase MJ (1999) Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol 73:482–494
65. Lau B, Poole E, Krishna B, Sellart I, Wills MR, Murphy E, Sinclair J (2016) The expression of human cytomegalovirus microRNA MiR-UL148D during latent infection in primary myeloid cells inhibits activin A-triggered secretion of IL-6. Sci Rep 6:31205. doi:10.1038/srep31205
66. Lelic A et al (2012) The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog 8:e1003076. doi:10.1371/journal.ppat.1003076
67. Lemmermann NA et al (2012) Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions. Med Microbiol Immunol 201:497–512. doi:10.1007/s00430-012-0257-y
68. Lisnic B, Lisnic VJ, Jonjic S (2015) NK cell interplay with cytomegaloviruses. Current opinion in virology 15:9–18. doi:10.1016/j.coviro.2015.07.001
69. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487–501
70. Loewendorf A, Kruger C, Borst EM, Wagner M, Just U, Messerle M (2004) Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J Virol 78:13062–13071. doi:10.1128/JVI.78.23.13062-13071.2004
71. Lucin P, Pavic I, Polic B, Jonjic S, Koszinowski UH (1992) Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 66:1977–1984
72. Marandu TF et al (2015) Immune protection against virus challenge in aging mice is not affected by latent herpesviral infections. J Virol 89:11715–11717. doi:10.1128/JVI.01989-15
73. Mason GM, Poole E, Sissons JG, Wills MR, Sinclair JH (2012) Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function. Proc Natl Acad Sci U S A 109:14538–14543. doi:10.1073/pnas.1204836109
74. Mason GM, Jackson S, Okecha G, Poole E, Sissons JG, Sinclair J, Wills MR (2013) Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4(+) T cells. PLoS Pathog 9:e1003635. doi:10.1371/journal.ppat.1003635
75. McSharry BP, Avdic S, Slobedman B (2012) Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation. Viruses 4:2448–2470. doi:10.3390/v4112448
76. Mekker A, Tchang VS, Haeberli L, Oxenius A, Trkola A, Karrer U (2012) Immune senescence: relative contributions of age and cytomegalovirus infection. PLoS Pathog 8:e1002850. doi:10.1371/journal.ppat.1002850
77. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, Jenkins MK (2007) Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27:203–213. doi:10.1016/j.immuni.2007.07.007
78. Munks MW, Pinto AK, Doom CM, Hill AB (2007) Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol 178:7235–7241
79. Murray SE et al. (2017) Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans J Exp Med doi:10.1084/jem.20161988
80. Nemcovicova I, Benedict CA, Zajonc DM (2013) Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions. PLoS Pathog 9:e1003224. doi:10.1371/journal.ppat.1003224
81. Noriega V, Redmann V, Gardner T, Tortorella D (2012) Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 54:140–151. doi:10.1007/s12026-012-8304-8
82. Oduro JD et al (2016) Murine cytomegalovirus (CMV) infection via the intranasal route offers a robust model of immunity upon mucosal CMV infection. J Gen Virol 97:185–195. doi:10.1099/jgv.0.000339
83. O'Hara GA, Welten SP, Klenerman P, Arens R (2012) Memory T cell inflation: understanding cause and effect. Trends Immunol 33:84–90. doi:10.1016/j.it.2011.11.005
84. Olson NC, Doyle MF, Jenny NS, Huber SA, Psaty BM, Kronmal RA, Tracy RP (2013) Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. PLoS One 8:e71498. doi:10.1371/journal.pone.0071498
85. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson BO, Ferguson FG (2001) Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121:187–201. doi:10.1016/s0047-6374(00)00210-4
86. Opal SM, DePalo VA (2000) Anti-inflammatory cytokines. Chest 117:1162–1172
87. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G (2004) Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol 39:607–613. doi:10.1016/j.exger.2003.11.016
88. Oxford KL et al (2015) The interplay between immune maturation, age, chronic viral infection and environment. Immun Ageing 12:3. doi:10.1186/s12979-015-0030-3
89. Palendira U et al (2008) Selective accumulation of virus-specific CD8(+) T cells with unique homing phenotype within the human bone marrow. Blood 112:3293–3302. doi:10.1182/blood-2008-02-138040
90. Pande NT, Powers C, Ahn K, Fruh K (2005) Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. J Virol 79:5786–5798. doi:10.1128/JVI.79.9.5786-5798.2005
91. Parry HM et al (2016) Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years. Immun Ageing 13:1. doi:10.1186/s12979-015-0056-6
92. Piedade D, Azevedo-Pereira JM (2016) MicroRNAs, HIV and HCV: a complex relation towards pathology. Rev Med Virol 26:197–215. doi:10.1002/rmv.1881
93. Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, Reddehase MJ (2000) Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 74:7496–7507
94. Polic B et al (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188:1047–1054
95. Poole E, King CA, Sinclair JH, Alcami A (2006) The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism. EMBO J 25:4390–4399. doi:10.1038/sj.emboj.7601287
96. Poole E, Atkins E, Nakayama T, Yoshie O, Groves I, Alcami A, Sinclair J (2008) NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86. J Virol 82:4250–4256. doi:10.1128/JVI.02156-07
97. Poole E, Groves I, MacDonald A, Pang Y, Alcami A, Sinclair J (2009) Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus. J Virol 83:3581–3590. doi:10.1128/JVI.02072-08
98. Poole E, Juss JK, Krishna B, Herre J, Chilvers ER, Sinclair J (2015) Alveolar macrophages isolated directly from human cytomegalovirus (HCMV)-seropositive individuals are sites of HCMV reactivation. In Vivo J Infect Dis 211:1936–1942. doi:10.1093/infdis/jiu837
99. Popovic B et al (2017) IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection. PLoS Pathog 13:e1006345. doi:10.1371/journal.ppat.1006345
100. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA (2007) The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 81:7759–7765. doi:10.1128/JVI.01262-06
101. Rawlinson WD, Farrell HE, Barrell BG (1996) Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70:8833–8849
102. Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH (1994) The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179:185–193
103. Redeker A, Welten SP, Arens R (2014) Viral inoculum dose impacts memory T-cell inflation. Eur J Immunol 44:1046–1057. doi:10.1002/eji.201343946
104. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 102:4140–4145. doi:10.1073/pnas.0408994102
105. Savva GM et al (2013) Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell 12:381–387. doi:10.1111/acel.12059
106. Schulz AR et al (2015) Low thymic activity and dendritic cell numbers are associated with the immune response to primary viral infection in elderly humans. J Immunol 195:4699–4711. doi:10.4049/jimmunol.1500598
107. Schwele S et al (2012) Cytomegalovirus-specific regulatory and effector T cells share TCR clonality—possible relation to repetitive CMV infections. Am J Transplant 12:669–681. doi:10.1111/j.1600-6143.2011.03842.x
108. Seckert CK et al (2011) Antigen-presenting cells of haematopoietic origin prime cytomegalovirus-specific CD8 T-cells but are not sufficient for driving memory inflation during viral latency. J Gen Virol 92:1994–2005. doi:10.1099/vir.0.031815-0
109. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE (2011) Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 6:e16103. doi:10.1371/journal.pone.0016103
110. Sims S, Bolinger B, Klenerman P (2015) Increasing inflationary T-cell responses following transient depletion of MCMV-specific memory T cells. Eur J Immunol 45:113–118. doi:10.1002/eji.201445016
111. Sinclair JH (2008) Human cytomegalovirus: latency and reactivation in the myeloid lineage. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 41:180–185. doi:10.1016/j.jcv.2007.11.014
112. Smith W et al (2013) Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host Microbe 13:324–335. doi:10.1016/j.chom.2013.02.003
113. Smithey MJ, Li G, Venturi V, Davenport MP, Nikolich-Zugich J (2012) Lifelong persistent viral infection alters the naive T cell pool, impairing CD8 T cell immunity in late life. J Immunol 189:5356–5366. doi:10.4049/jimmunol.1201867
114. Snyder CM, Cho KS, Bonnett EL, van Dommelen S, Shellam GR, Hill AB (2008) Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29:650–659. doi:10.1016/j.immuni.2008.07.017
115. Snyder CM, Cho KS, Bonnett EL, Allan JE, Hill AB (2011) Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog 7:e1002295. doi:10.1371/journal.ppat.1002295
116. Spyridopoulos I et al (2016) CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study. Aging Cell 15:389–392. doi:10.1111/acel.12430
117. Stern JL, Slobedman B (2008) Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1. J Immunol 180:6577–6585
118. Stern-Ginossar N et al (2007) Host immune system gene targeting by a viral miRNA. Science 317:376–381. doi:10.1126/science.1140956
119. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R (2007) Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 42:563–570. doi:10.1016/j.exger.2007.01.005
120. Strindhall J et al (2013) The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr) 35:985–991. doi:10.1007/s11357-012-9400-3
121. Strindhall J, Ernerudh J, Morner A, Waalen K, Lofgren S, Matussek A, Bengner M (2016) Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio. Infect Dis 48:436–442. doi:10.3109/23744235.2015.1135252
122. Sturgill ER et al (2016) Natural killer cell evasion is essential for infection by rhesus cytomegalovirus. PLoS Pathog 12:e1005868. doi:10.1371/journal.ppat.1005868
123. Sylwester AW et al (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202:673–685. doi:10.1084/jem.20050882
124. Terrazzini N et al (2014) A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology. J Infect Dis 209:1382–1392. doi:10.1093/infdis/jit576
125. Theeten H et al (2016) Cellular interferon gamma and Granzyme B responses to cytomegalovirus-pp65 and influenza N1 are positively associated in elderly viral. Immunol 29:169–175. doi:10.1089/vim.2015.0071
126. Torti N, Walton SM, Brocker T, Rulicke T, Oxenius A (2011) Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog 7:e1002313. doi:10.1371/journal.ppat.1002313
127. Tovar-Salazar A, Patterson-Bartlett J, Jesser R, Weinberg A (2010) Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells. Virology 398:158–167. doi:10.1016/j.virol.2009.11.038
128. Trzonkowski P et al (2003) Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination—an impact of immunosenescence. Vaccine 21:3826–3836. doi:10.1016/S0264-410x(03)00309-8
129. Tu W et al (2004) Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 172:3260–3267
130. Turner JE et al (2014) Rudimentary signs of immunosenescence in cytomegalovirus-seropositive healthy young adults. Age (Dordr) 36:287–297. doi:10.1007/s11357-013-9557-4
131. Verma S, Loewendorf A, Wang Q, McDonald B, Redwood A, Benedict CA (2014) Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense. PLoS Pathog 10:e1004268. doi:10.1371/journal.ppat.1004268
132. Verma S, Weiskopf D, Gupta A, McDonald B, Peters B, Sette A, Benedict CA (2015) Cytomegalovirus-specific CD4 T cells are cytolytic and mediate vaccine protection. J Virol 90:650–658. doi:10.1128/JVI.02123-15
133. Vescovini R et al (2004) Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8(+) T cells. Exp Gerontol 39:1233–1243. doi:10.1016/j.exger.2004.04.004
134. Vescovini R et al (2007) Massive load of functional effector CD4(+) and CD8(+) T cells against cytomegalovirus in very old subjects. J Immunol 179:4283–4291
135. Vescovini R et al (2014) Naive and memory CD8 T cell pool homeostasis in advanced aging: impact of age and of antigen-specific responses to cytomegalovirus. Age (Dordr) 36:625–640. doi:10.1007/s11357-013-9594-z
136. Wagner M, Gutermann A, Podlech J, Reddehase MJ, Koszinowski UH (2002) Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med 196:805–816
137. Wald A, Selke S, Magaret A, Boeckh M (2013) Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults. J Med Virol 85:1557–1560. doi:10.1002/jmv.23642
138. Walton SM, Mandaric S, Torti N, Zimmermann A, Hengel H, Oxenius A (2011) Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells. PLoS Pathog 7:e1002214. doi:10.1371/journal.ppat.1002214
139. Ware CF (2003) The TNF superfamily. Cytokine Growth Factor Rev 14:181–184
140. Weltevrede M, Eilers R, de Melker HE, van Baarle D (2016) Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review. Exp Gerontol 77:87–95. doi:10.1016/j.exger.2016.02.005
141. Wertheimer AM et al (2014) Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol 192:2143–2155. doi:10.4049/jimmunol.1301721
142. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37:445–453
143. Wilkinson GW et al (2008) Modulation of natural killer cells by human cytomegalovirus. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 41:206–212. doi:10.1016/j.jcv.2007.10.027
144. Willis EL, Eberle R, Wolf RF, White GL, McFarlane D (2014) The effects of age and cytomegalovirus on markers of inflammation and lymphocyte populations in captive baboons. PLoS One 9:e107167. doi:10.1371/journal.pone.0107167
145. Wills MR, Poole E, Lau B, Krishna B, Sinclair JH (2015) The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? Cell Mol Immunol 12:128–138. doi:10.1038/cmi.2014.75
146. Yue Y, Kaur A, Lilja A, Diamond DJ, Walter MR, Barry PA (2016) The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains. J Gen Virol 97:1426–1438. doi:10.1099/jgv.0.000455
147. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28:445–489. doi:10.1146/annurev-immunol-030409-101212